Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations
Article in Pharmacogenomics (March 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
The effect of genetic variants in the transcription factor TSPYL family on the CYP3A4 mediated cyclosporine metabolism in kidney transplant patients
Article in Clinical and Translational Science (February 2024)
Effect of CYP3A4*22, CYP3A5*3 and POR*28 genetic polymorphisms on calcineurin inhibitors dose requirements in early phase renal transplant patients
Article in Pharmacogenetics and Genomics (December 2023)